INTRODUCTION
Tuberculosis is a global health problem with 8.8 million patients reported in 2010, and causing 1.1 million deaths in the world. 1 It is a major health burden in Sri Lanka as well, with an annual incidence of 46 per 100000 population leading to 1900 deaths in 2010. 2 Unlike other infections, treatment of tuberculosis requires administration of several antibiotics together for a long period of time, exposing patients to a signifi cant risk from drug side effects. Literature provides information that serious adverse reactions induced by antituberculosis (anti-TB) drugs also contribute to the increased morbidity and mortality of tuberculosis infection. Therefore, special emphasis on adverse effects of anti-TB drugs is required in the management of tuberculosis. 3 The commonest adverse reaction to antituberculosis drugs is dyspepsia but hepatitis and skin reactions 4 are 2 of the signifi cant reactions that lead to interruption of therapy and use of alternative drugs. The rate of side effects of Anti-TB drugs has a geographical variation and higher rates are observed in India compared with the west. The incidence of anti TB drug induced hepatitis is around 9.5% 5 in Sri Lanka but the incidence of skin reactions is not known. Hepatitis can be fatal and skin reactions can lead to exfoliative dermatitis which can be fatal as well.
All four category 1 medications are known to cause exfoiative dermatitis. 6 In addition side-effects such as hepatitis, dyspepsia, exanthema and arthralgia are responsible for termination of therapy in up to 23% of patients during the intensive phase. 7 Age, gender, body weight and consumption of alcohol have been described as risk factors for the development of anti TB drug induced hepatitis. 5 Identifi cation of high-risk patients would be useful to allow early detection of adverse reactions and to reduce the morbidity and mortality. 8 However, the role of drug or food allergy as a risk factor has not been studied. We noticed the increase in incidence of anti-TB drug induced adverse effects in patients with history of drug or food allergies during the past years, which prompted us to perform this study and to provide objective evidence through this study. Immune reactions have been described as mechanisms of such allergies as well as adverse reactions making a possible link between the two. This study was carried out to fi nd out whether allergy to drug or food acts as a risk factor for the development of anti-tuberculosis drug induced hepatitis or skin reactions. Study population was the patients with tuberculosis who presented to the Respiratory Unit of Teaching Hospital Kandy and Chest Clinic Kandy due to anti-tuberculosis drug induced hepatitis or skin reactions. Out of them the patients who fulfi lled the following inclusion criteria were enrolled in to the study. 
METHODOLOGY

Defi nitions
Cases:
Cases were defi ned as the patients with tuberculosis, who fulfi lled inclusion and exclusion criteria, who developed anti-TB drug induced hepatitis or skin reactions during the 6 month treatment period.
Anti-TB drug induced hepatitis:
The defi nition used by Rohit Singla et al was used with slight modifi cation for our study. 10 Anti TB drug induced hepatitis was defi ned if any one of the following 1 to three criteria were met along with criteria 4. 4. Improvement in liver functions (serum bilirubin < 1 mg/dl, AST and ALT <100) after withdrawal of anti-TB drugs.
Anti-TB drug induced skin reactions:
Anti-TB drug induced skin reactions were defi ned as presence of following criteria.
1. Any rash or skin eruption with or without itching that occurs after the start of anti-TB drugs 2. Disappearance of such symptoms and signs following the withdrawal of anti TB drugs and reappearance of the same symptoms and signs when anti TB drugs were reintroduced
Food or drug allergy
Food or drug allergy was defi ned as documented urticaria, angioedema, skin eruption or anaphylaxis directly related to the ingestion of a particular food or drug.
Controls
Controls were defi ned as patients with tuberculosis on category 1 regimen, who had no exclusion criteria and who didn't develop hepatitis or skin reactions during the 6 month treatment period.
Cases and controls were inquired for the presence of allergy to drugs or food and were recorded using an interviewer administered questionnaire. 
Matching
Controls were matched with cases for age, gender, weight and consumption of alcohol which are confounding factors for the development of anti TB drug induced hepatitis. One matched control was chosen for an each case.
Statistical analysis
Due to the limited study period and low incidence of adverse reactions all consecutive cases were enrolled and analyzed. Characteristics of cases and controls were compared using percentages. Incidence of anti-TB drug induced hepatitis or skin reactions were analyzed using absolute numbers as well as percentages. Food or drug allergy in each group was similarly analyzed using absolute numbers and percentages. Incidence of hepatitis or skin reaction by each drug was calculated with percentages for descriptive purposes. Strength of association between allergy and drug induced hepatitis or skin reaction was assessed using odds ratio. Confi dence interval for signifi cance was set at 95% for analysis of odds ratio.
RESULTS
A total of 122 patients were included in the study. Out of them 61 were cases and 61 were controls. Offending drug was identifi ed during the desensitization process in 18 patients (29.5%) and all of them had to be put on an alternative regimen excluding the offending drug. All the alternative regimens had to be continued for more than 6 months. Main culprit drug out of the identifi ed drugs was pyrazinamide which caused hepatitis in 10 patients (out of 41 hepatitis patients) (24.5%). 
DISCUSSION
This study shows that patients with history of drug or food allergy have 5.8 times risk of developing anti-TB drug induced hepatitis or skin reactions. Although many risk factors for anti-TB drug induced adverse reactions have been described, drug and food allergy as risk factor has not been described in medical literature so far. Sri Lankan diet includes both vegetarian as well as nonvegetarian components food and drug reactions are a common occurrence in day today medical practice.
Adverse reactions to anti-TB drugs are a major concern because of their seriousness as well as the higher frequency of incidence. Most of the reactions are idiosyncratic (they cannot be predicted and not dose dependent).Isoniazid induced hepatitis is thought to be idiosyncratic and is driven by a toxic metabolite of the parent drug. 8 The mechanism of rifampicin induced hepatotoxicity is not known but is unpredictable. Unlike in isoniazid, a toxic metabolite is not the cause. Mechanism of pyrazinamide hepatotoxicity is also not known but its effects are thought to be due to dose dependent mechanism as well as idiosyncratic reactions. Ethambutol is not known to be hepatotoxic. Incidence of hepatitis caused by each drug is diffi cult to assess as these drugs are used in combination. 9 There are many mechanisms of drug allergies as well as food allergies. A signifi cant proportion of them are idiosyncratic. These idiosyncratic reactions are immune mediated. 11 Therefore it is possible that patients with drug and food allergy are immunologically susceptible to anti-TB drug induced hepatitis and skin reactions. Cross allergy between drugs have been very well described in medical literature. For example a patient with penicillin allergy could develop an allergic reaction to cephalosporin if exposed, due to cross allergy.
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Similarly a person with allergy to one food type can have a cross allergy to other food types as well. This cross allergy could be a reason for the development of anti-TB drug induced adverse reactions in patients with drug and food allergy.
Finding of an association between drug or food allergy and anti -TB drug induced adverse reactions can have a signifi cant impact on the management of patients with tuberculosis.
Starting anti-TB drugs in a patient with history of drug and food allergy should be a cautious procedure and special protocols on initiation of these medications on such patients are necessary to minimize reactions and to improve compliance. At the moment there is no way of predicting drug reactions. Therefore close monitoring of patients with risk factors, especially if there is a history of drug and food allergy should be practiced.
As with previous medical literature 8 pyrazinamide was the main culprit for anti-TB drug induced hepatitis in our study. But the offending drug could be identifi ed in only 29.5%.This makes prediction of reactions even more diffi cult.
All though anti-TB drug induced hepatitis and skin reactions are separate sub groups, due to the limited time frame and low incidence, the numbers were too small to do a sub group analysis. However a sub group analysis will be done in a future study to clarify the association among individual sub groups.
A cohort study will be necessary to confi rm the exact causal relationship suggested in this study.
CONCLUSION
Patients with allergy to drug or food have 5.8 times risk of developing anti-tuberculosis drug induced hepatitis or skin reaction during standard regimen for tuberculosis. Therefore commencing anti-TB drugs on such patients should be a cautious procedure and special protocols may be necessary to minimize these major adverse reactions.
